18:50:54 EDT Fri 18 Jul 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

V:LSL - LSL Pharma Group Inc. - https://www.groupelslpharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
LSL - V  4.00.42·0.4319.00.43+0.037.523.29150.405  0.43  0.4050.50  0.2915:19:13Jul 0315 min RT 2¢
TSX-V - V4.00.42·0.4319.00.43+0.037.520.58100.405  0.43  0.4050.50  0.2915:19:1315 min
CX2 - H 0.405+0.0051.32.0120.405  0.405  0.40511:00:0215 min
CXD - D 0.400.703    Jun 2315 min

Recent Trades - Last 10 of 15
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:19:13V0.430.035001 Anonymous7 TD SecK
14:22:29D0.430.034080 National Bank80 National BankE
14:09:45V0.430.031,00080 National Bank7 TD SecK
14:09:45D0.430.0340080 National Bank80 National BankE
13:29:22V0.430.035,00098 Red Cloud7 TD SecK
12:51:58D0.4350.035230124 Questrade7 TD SecE
12:40:47V0.430.031,00098 Red Cloud79 CIBCK
12:40:47V0.430.033,00098 Red Cloud7 TD SecK
11:00:02V0.430.033,50085 Scotia1 AnonymousK
11:00:02V0.4250.0252,00085 Scotia1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-07-03 03:50C:LSL0.39News ReleaseLSL Pharma trustee to redeem $3.28M in debentures
2025-06-27 19:09C:LSL0.40News ReleaseLSL Pharma shareholders elect four directors at AGM
2025-06-27 11:09C:LSL0.39News ReleaseLSL Pharma arranges $7.5M credit line, $10M term loan
2025-05-29 07:00C:LSL0.375News ReleaseLSL PHARMA GROUP REPORTS RECORD REVENUES AND FIRST QUARTER 2025 RESULTS
2025-05-28 17:36C:LSL0.375SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-05-28 17:36C:LSL0.375SEDAR Interim MD & ASEDAR Interim MD & A
2025-05-01 07:39C:LSL0.35News ReleaseLSL PHARMA GROUP REPORTS ITS FOURTH QUARTER AND YEAR-END 2024 RESULTS
2025-04-30 17:08C:LSL0.35SEDAR Annual ReportSEDAR Annual Report
2025-04-30 17:01C:LSL0.35SEDAR MD & ASEDAR MD & A
2025-04-30 16:55C:LSL0.35SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-04-29 07:00C:LSL0.345News ReleaseLSL PHARMA GROUP INC. ANNOUNCES ITS PARTICIPATION IN THE "2025 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE"
2025-04-23 16:14C:LSL0.34MiscellaneousLSL Pharma debentures amended
2025-04-23 13:33C:LSL0.335News ReleaseLSL Pharma to pay debenture interest April 30
2025-04-03 16:07C:LSL0.34News ReleaseLSL signs deals to sell eye drops in Canada
2025-03-31 16:12C:LSL0.335News ReleaseLSL Pharma appoints Laflamme as director
2025-03-18 18:58C:LSL0.335MiscellaneousLSL Pharma two million bonus warrants
2025-01-22 18:33C:LSL0.405News ReleaseLSL Pharma grants options to buy 625,000 shares
2024-12-18 17:13C:LSL0.40News ReleaseLSL Pharma acquires Dermolab, closes note financing
2024-11-25 07:00C:LSL0.43News ReleaseLSL PHARMA GROUP ANNOUNCES STRONG FISCAL Q3-24 RESULTS AND $2.4 MILLION DEBT FINANCINGS TO SUPPORT ITS GROWTH INITIATIVES
2024-11-22 17:53C:LSL0.43SEDAR Interim MD & ASEDAR Interim MD & A